RENOVOGEM Trademark

Trademark Overview

On Monday, August 21, 2023, a trademark application was filed for RENOVOGEM with the United States Patent and Trademark Office. The USPTO has given the RENOVOGEM trademark a serial number of 98142360. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, November 18, 2025. This trademark is owned by RenovoRx, Inc.. The RENOVOGEM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer
renovogem

General Information

Serial Number98142360
Word MarkRENOVOGEM
Filing DateMonday, August 21, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, November 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 19, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRenovoRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Altos, CA 94022
Party NameRenovoRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Altos, CA 94022

Trademark Events

Event DateEvent Description
Friday, August 25, 2023NEW APPLICATION ENTERED
Tuesday, September 19, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 18, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 18, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 19, 2024ASSIGNED TO EXAMINER
Friday, April 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 30, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 30, 2024SOU EXTENSION 1 FILED
Monday, December 30, 2024SOU EXTENSION 1 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 22, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, July 22, 2025SOU EXTENSION 2 FILED
Tuesday, July 22, 2025SOU EXTENSION 2 GRANTED
Wednesday, July 23, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 18, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, November 18, 2025SOU EXTENSION 3 FILED
Tuesday, November 18, 2025SOU EXTENSION 3 GRANTED
Wednesday, November 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

renovogem cancer treatment prevention products pharmaceutical